Efficacy and Safety Study of VB-1953 Topical Gel for Inflammatory Facial Acne Vulgaris
Public ClinicalTrials.gov record NCT03900676. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Randomized, Multicenter, Double-blind, Vehicle-controlled, Dose-ranging Study to Evaluate the Efficacy and Safety of VB-1953 Topical Gel When Applied Once or Twice Daily for 12 Weeks in Subjects With Moderate to Severe Inflammatory Facial Acne Vulgaris
Study identification
- NCT ID
- NCT03900676
- Recruitment status
- Not listed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Vyome Therapeutics Inc.
- Industry
- Enrollment
- 480 participants
Conditions and interventions
Conditions
Interventions
- VB-1953 - 2% Drug
- VB-1953 - 0% (Vehicle) Drug
Drug
Eligibility (public fields only)
- Age range
- 9 Years to 45 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 8, 2019
- Primary completion
- Oct 31, 2019
- Completion
- Feb 29, 2020
- Last update posted
- Sep 30, 2019
2019 – 2020
United States locations
- U.S. sites
- 12
- U.S. states
- 6
- U.S. cities
- 11
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Vyome Therapeutics Inc. | Ontario | California | 91762 | — |
| Vyome Therapeutics Inc. | Sherman Oaks | California | 91403 | — |
| Vyome Therapeutics Inc. | Brandon | Florida | 33511 | — |
| Vyome Therapeutics Inc. | Coral Gables | Florida | 33134 | — |
| Vyome Therapeutics Inc | Miami | Florida | 33126 | — |
| Vyome Therapeutics Inc. | Winter Park | Florida | 32792 | — |
| Vyome Therapeutics Inc. | High Point | North Carolina | 27262 | — |
| Vyome Therapeutics Inc. | Hazleton | Pennsylvania | 18201 | — |
| Vyome Therapeutics Inc. | Upper Saint Clair | Pennsylvania | 15241 | — |
| Vyome Therapeutics Inc. | Mt. Pleasant | South Carolina | 29464 | — |
| Vyome Therapeutics Inc. | El Paso | Texas | 79902 | — |
| Vyome Therapeutics Inc. | El Paso | Texas | 79928 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03900676, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 30, 2019 · Synced Jul 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03900676 live on ClinicalTrials.gov.